P2Y1 antagonist 3
P2Y1 antagonist 3 (compound 36b) is a blood-brain barrier (BBB) -penetrant P2Y1 antagonist with an IC50 of 0.50 μM. P2Y1 antagonist 3 exhibits protective effects in a rat middle cerebral artery occlusion (MCAO) model and demonstrates neuroprotective activity against oxidative stress by upregulating nuclear Nrf2 protein levels[1].
Product Specifications
UNSPSC
12352005
Target
P2Y Receptor
Related Pathways
GPCR/G Protein
Field of Research
Neurological Disease
Smiles
OC(C1=CN=C(C2=CC=CC(C#N)=C2)N=C1OC3=CC=CC(C#N)=C3)=O
Molecular Formula
C19H10N4O3
Molecular Weight
342.31
References & Citations
[1]Zhang B, et al. Design, Synthesis, and Biological Evaluation of 4- (Difluoromethyl) -1H-imidazole-5-carboxylic Acids/4- (3-Cyanophenoxy) pyrimidine-5-carboxylic Acids as P2Y1 Receptor Antagonists for Ischemic Stroke Treatment. J Med Chem. 2025 Jun 12;68 (11) :10930-10952.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB2295-100 1x 100 µL
Parathyroid Hormone (PTH) (N-Terminal) (PTH/2295R), 0.2mg/mL
Sign In for Pricing
View Details 
